TNF and Hermansky-Pudlak syndrome: Consistent with those findings, we previously reported that rosuvastatin alleviated experimental HPS through the inhibition of pulmonary inflammatory angiogenesis, which was related to the down-regulation of the tumor necrosis factor-α (TNF-α)/nuclear factor kappa B (NFκB) and VEGF/Rho-A pathways [17].